Molecularly Targeted Therapy in Breast Cancer: The New Generation

E-ISSN： 2212-3970|3|2|100-104

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.3, Iss.2, 2008-06, pp. : 100-104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monoclonal Antibody-Based Targeted Therapy in Breast Cancer

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, Iss. 2, 2005-03 ,pp. : 99-106

Bentham Science Publishers

Access to resources Recommend Favorite

Subdivision of molecularly-classified groups by new gene signatures in breast cancer patients

By Armakolas Athanasios Stathopoulos George P. Nezos Adrianos Theos Apostolos Stathaki Martha Koutsilieris Michael

Oncology Reports, Vol. 28, Iss. 6, 2012-12 ,pp. : 2255-2263

Spandidos Publications

Access to resources Recommend Favorite

Primary systemic therapy for operable breast cancer patients: the need for the new generation of trial design

By Alvarez Ricardo

Breast Cancer Research and Treatment, Vol. 124, Iss. 3, 2010-12 ,pp. : 701-705

Springer Publishing Company

Access to resources Recommend Favorite

Non-Small Cell Lung Cancer: From Cytotoxic Systemic Chemotherapy to Molecularly Targeted Therapy

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 4, Iss. 3, 2004-05 ,pp. : 231-245

Bentham Science Publishers

Access to resources Recommend Favorite

Molecularly Targeted Therapy for Pediatric Brain Tumors

By KE Warren

Journal of Neuro-Oncology, Vol. 75, Iss. 3, 2005-12 ,pp. : 335-343

Springer Publishing Company

Access to resources Recommend Favorite